Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-06 8:21 pm |
Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel |
5,330 | $3.0712 | $16,369 | 66,014 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 8:10 pm |
Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer |
8,232 | $3.0712 | $25,282 | 150,284 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 8:08 pm |
Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks |
14,283 | $3.0712 | $43,866 | 158,210 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 8:02 pm |
Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer |
18,791 | $3.0712 | $57,710 | 1,622,251 (Direct) |
View |
| 2024-11-14 Purchase |
2024-11-18 7:20 pm |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
20,000 | $3.7 | $74,000 | 31,250 (Direct) |
View |
| 2024-11-06 Sale |
2024-11-08 7:24 pm |
Tango Therapeutics Inc. | TNGX | EcoR1 Capital LLC 10% Owner |
2,700,000 | $3.1243 | $8,435,743 | 10,630,736 (Indirect) |
View |
| 2024-11-06 Sale |
2024-11-07 9:30 pm |
Tango Therapeutics Inc. | TNGX | Boxer Capital Management LLC Davis Aaron I. See remarks |
3,080,000 | $3.14 | $9,671,200 | 10,707,885 (Indirect) |
View |
| 2024-10-25 Sale |
2024-10-28 06:59 am |
Tango Therapeutics Inc. | TNGX | Boxer Capital Management LLC Davis Aaron I. See remarks. |
633,000 | $6.87 | $4,348,710 | 13,787,885 (Indirect Direct) |
View |
| 2024-10-21 Sale |
2024-10-23 9:31 pm |
Tango Therapeutics Inc. | TNGX | Boxer Capital Management LLC Davis Aaron I. See remarks |
875,000 | $6.9729 | $6,101,250 | 14,420,885 (Indirect Direct) |
View |
| 2024-09-13 Sale |
2024-09-17 4:48 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
67,400 | $10.53 | $709,756 | 16,859,075 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-09 7:19 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
75,000 | $11.56 | $867,135 | 16,926,475 (Direct) |
View |
| 2024-08-30 Sale |
2024-09-04 8:42 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
175,000 | $11.6 | $2,029,703 | 17,001,475 (Direct) |
View |
| 2024-08-27 Sale |
2024-08-29 4:40 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
25,000 | $11.55 | $288,665 | 17,176,475 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-20 5:59 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
285,000 | $9.9487 | $2,835,368 | 17,201,475 (Direct) |
View |
| 2024-07-30 Sale |
2024-08-01 5:51 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
235,000 | $9.8574 | $2,316,494 | 17,486,475 (Direct) |
View |
| 2024-07-26 Sale |
2024-07-30 4:15 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
50,000 | $9.839 | $491,950 | 17,721,475 (Direct) |
View |
| 2024-07-24 Sale |
2024-07-26 4:15 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
300,599 | $9.8335 | $2,955,931 | 17,771,475 (Direct) |
View |
| 2024-07-22 Sale |
2024-07-24 4:15 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
387,740 | $9.7835 | $3,793,446 | 18,072,074 (Direct) |
View |
| 2024-07-18 Sale |
2024-07-22 4:15 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
191,490 | $9.8098 | $1,878,479 | 18,459,814 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-18 4:15 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
550,171 | $9.7903 | $5,386,339 | 18,651,304 (Direct) |
View |
| 2024-06-28 Sale |
2024-07-02 8:56 pm |
Tango Therapeutics Inc. | TNGX | MVA Investors LLC Davis Aaron I. See remarks |
234,731 | $8.756 | $2,055,314 | 108,793 (Direct) |
View |
| 2024-06-06 Sale |
2024-06-07 9:14 pm |
Tango Therapeutics Inc. | TNGX | MVA Investors LLC Davis Aaron I. See remarks |
140,000 | $7.042 | $985,880 | 348,524 (Indirect Direct) |
View |
| 2024-06-05 Sale |
2024-06-07 5:16 pm |
Tango Therapeutics Inc. | TNGX | Calhoun Lesley Ann Director |
5,000 | $7.2078 | $36,039 | 43,750 (Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 9:34 pm |
Tango Therapeutics Inc. | TNGX | MVA Investors LLC Davis Aaron I. See remarks |
210,000 | $7.5279 | $1,580,850 | 488,524 (Indirect) |
View |
| 2024-02-20 Sale |
2024-02-21 5:52 pm |
Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
162,500 | $12 | $1,950,000 | 19,201,475 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 9:14 pm |
Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer |
9,138 | $12.59 | $115,052 | 1,535,167 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 9:09 pm |
Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel |
2,776 | $12.59 | $34,951 | 43,981 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 9:08 pm |
Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer |
3,725 | $12.59 | $46,900 | 132,397 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 9:04 pm |
Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks |
8,371 | $12.59 | $105,395 | 119,478 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Option Award |
2025-02-05 8:14 pm |
N/A 2035-02-03 |
Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer |
182,832 | $0 | 315,229 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 7:34 pm |
N/A 2035-02-03 |
Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks |
371,105 | $0 | 490,583 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 7:31 pm |
N/A 2035-02-03 |
Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer |
741,125 | $0 | 2,276,292 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-05 7:30 pm |
N/A 2035-02-03 |
Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel |
191,538 | $0 | 235,519 (Direct) |
View |
Ownership |
2024-10-22 8:48 pm |
N/A N/A |
Tango Therapeutics Inc. | TNGX | Boxer Capital Management LLC See remarks. |
0 | $0 | 10,539,221 (Indirect) |
View |
| 2024-09-03 Other |
2024-09-05 9:01 pm |
N/A 2034-09-03 |
Tango Therapeutics Inc. | TNGX | Davis Aaron I. See remarks. |
65,000 | $0 | 65,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:21 pm |
N/A 2034-06-05 |
Tango Therapeutics Inc. | TNGX | Peters Malte Director |
43,750 | $0 | 48,750 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:17 pm |
N/A 2034-06-05 |
Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director |
43,750 | $0 | 48,750 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:16 pm |
N/A 2034-06-05 |
Tango Therapeutics Inc. | TNGX | Calhoun Lesley Ann Director |
43,750 | $0 | 43,750 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:13 pm |
N/A 2034-06-05 |
Tango Therapeutics Inc. | TNGX | Ketchum John B Director |
32,812 | $0 | 42,812 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:11 pm |
N/A 2034-06-05 |
Tango Therapeutics Inc. | TNGX | Borisy Alexis Director |
43,750 | $0 | 48,750 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 4:27 pm |
N/A 2034-02-01 |
Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer |
275,888 | $0 | 275,888 (Direct) |
View |